MYGN logo

MYGN

Myriad Genetics Inc.

$6.37
+$0.15(+2.41%)
38
Overall
--
Value
33
Tech
44
Quality
Market Cap
$540.59M
Volume
2.58M
52W Range
$3.76 - $29.30
Target Price
$7.42
Order:

Income Statement

MetricTrendChart
2015
Jun
2016
Jun
2017
Jun
2018
Jun
2019
Jun
2020
Jun
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$723.1M$753.8M$769.9M$743.7M$851.1M$638.6M$690.6M$678.4M$753.2M$837.6M
Total Revenue
$722.5M$740.5M$769.9M$743.7M$851.1M$638.6M$690.6M$678.4M$753.2M$837.6M
COST OF GOODS SOLD
Cost of Revenue
$-132.8M$-132.8M$-145.2M$-148.7M$168.2M$186.1M$197.6M$202.0M$236.2M$252.2M
GROSS PROFIT
Gross Profit
$575.7M$596.5M$598.7M$566.5M$682.9M$452.5M$504.9M$476.4M$517.0M$585.4M
OPERATING EXPENSES
Operating Expenses
$441.5M$429.7M$550.8M$505.8M$641.4M$584.5M$619.7M$600.1M$774.4M$708.9M
Research & Development
$75.5M$70.6M$74.4M$70.8M$85.9M$77.2M$81.9M$85.4M$88.7M$113.4M
Research Expense
$75.5M$70.6M$74.4M$70.8M$85.9M$77.2M$81.9M$85.4M$88.7M$113.4M
Selling, General & Administrative
$366.0M$359.1M$476.4M$435.0M$555.5M$507.3M$537.8M$514.7M$572.9M$560.0M
Selling & Marketing Expenses
$366.0M$359.1M$476.4M$435.0M--------$289.2M$284.1M
General & Administrative Expenses
$-13.8M$-14.3M$-15.2M$-15.5M$555.5M$507.3M$537.8M$514.7M$283.7M$275.9M
Salaries & Wages
$-45.7M$-31.6M$-29.9M$-27.1M$33.5M$25.2M$36.3M$38.1M----
Depreciation & Amortization
$-25.0M$-26.7M$-48.3M$-54.4M$73.0M$11.0M$12.1M$11.6M$19.1M$19.5M
Depreciation & Amortization
$-25.0M$-26.7M$-48.3M$-54.4M$73.0M$11.0M$12.1M$11.6M----
Amortization
$-12.7M$-12.6M$-33.3M$-37.3M$684.7M$-7.3M$404.1M$379.7M$287.4M$286.3M
Other Operating Expenses
$-1.1M$-600.0K$-700.0K$-600.0K$-2.2M$-1.6M$-1.4M$-12.9M----
OPERATING INCOME
Operating income
$134.2M$166.8M$47.9M$60.7M$7.6M$-231.7M$-190.5M$-140.6M$-257.4M$-123.5M
EBITDA
$159.9M$195.9M$89.6M$174.7M$73.4M$-140.5M$12.3M$-84.7M$-197.4M$-50.0M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$300.0K$6.0M$3.2M$12.0M$10.8M$6.6M$3.2M$2.9M$2.8M
Intinc
$400.0K$900.0K$1.2M$1.8M$3.2M$3.0M$700.0K$2.6M$2.5M$1.7M
Net Non-Operating Interest Income/Expense
$400.0K$600.0K$-4.8M$-1.4M$-8.8M$-7.8M$-5.9M$-600.0K$-400.0K$-1.1M
Other Income/Expense
$-300.0K$-1.5M$2.2M$-60.8M$-100.0K$-16.2M$-139.3M$-16.3M$4.4M$-1.1M
Other Special Charges
$300.0K$1.5M$-3.0M$-400.0K$1.2M$16.2M$139.3M$600.0K$-4.4M$1.1M
SPECIAL ITEMS
Restructring And Mn A Income
$-134.2M$-102.2M$-41.2M--------------
Special Income Charges
$134.2M$102.2M$41.2M----$-99.7M$-63.8M$-16.9M$-112.8M$-56.8M
Impairment of Capital Assets
----------$99.7M$1.8M$16.9M--$56.8M
PRE-TAX INCOME
EBIT
$134.9M$169.2M$41.3M$120.3M$400.0K$-212.5M$-50.5M$-137.4M$-259.3M$-120.7M
Pre-Tax Income
$134.9M$168.9M$40.9M$120.1M--$-223.3M$-57.1M$-140.6M$-262.2M$-123.5M
INCOME TAX
Tax Provision
$54.7M$43.6M$20.6M$-13.0M$-4.4M$-23.7M$-29.9M$-28.6M$1.1M$3.8M
NET INCOME
Net Income
$80.2M$125.3M$20.5M$133.3M$4.6M$-199.5M$-27.2M$-112.0M$-263.3M$-127.3M
Net Income (Continuing Operations)
$80.2M$125.3M$20.5M$133.3M$4.6M$-199.5M$-27.2M$-112.0M$-263.3M$-127.3M
Net Income (Discontinued Operations)
$80.2M$125.3M$20.5M$133.3M$4.6M$-199.5M$-27.2M$-112.0M$-263.3M$-127.3M
Net Income (Common Stockholders)
$80.2M$125.3M$20.5M$133.3M$4.6M$-199.5M$-27.2M$-112.0M$-263.3M$-127.3M
TOTALS
Total Expenses
$308.7M$296.9M$405.6M$357.1M$809.6M$742.0M$805.4M$802.1M$1.0B$961.1M
SHARE & EPS DATA
Average Shares Outstanding
$71.3M$70.0M$68.3M$69.4M$73.5M$74.3M$78.0M$80.6M$82.8M$90.6M
Average Shares Outstanding (Diluted)
$74.5M$73.4M$68.8M$72.0M$76.0M$74.3M$78.0M$80.6M$82.8M$90.6M
Shares Outstanding
$68.6M$69.1M$68.4M$70.9M$73.9M$74.7M$80.0M$81.2M$89.9M$182.6M
Basic EPS
$1.12$1.79$0.30$1.92$0.06$-2.69$-0.35$-1.39$-3.18$-1.41
Basic EPS (Continuing Operations)
--------$0.06$-2.69$-0.35$-1.39$-3.18$-1.41
Diluted EPS
$1.08$1.71$0.30$1.85$0.06$-2.69$-0.35$-1.39$-3.18$-1.41
Diluted EPS (Continuing Operations)
--------$0.06$-2.69$-0.35$-1.39$-3.18$-1.41
OTHER METRICS
Gain On Sale Of Business
----------$1.0M--------
Gain On Sale Of P P E
----------$1.0M$162.0M------
Interest Expense Operating
----$-5.6M$-3.0M$-11.6M$-9.5M$-4.4M------
Minority Interests
----$200.0K$200.0K$200.0K$100.0K--------
Non Recurring Operation Expense
------------$62.0M--$112.8M--
Other Gand A
$-13.8M$-14.3M$-15.2M$-15.5M$555.5M$507.3M$537.8M$514.7M$283.7M$275.9M
Other Impairment Of Capital Assets
----------$17.7M--------
Rent And Landing Fees
$-13.8M$-14.3M$-15.2M$-15.5M$19.7M----------
Selling Expense
$366.0M$359.1M$476.4M$435.0M------------
Restruct
$-134.2M$-102.2M$-41.2M--------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2MYGN$6.37+2.4%2.58M
3
4
5
6

Get Myriad Genetics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.